Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia

doi:10.4252/wjsc.v6.i4.473

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8858)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

539

WORD

325

HTML

5794

Figures (1-2)

173

Sum=6831

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

957

Download

1070

Sum=2027

Sep 26, 2014 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (51)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Stem Cells. Sep 26, 2014; 6(4): 473-484
Published online Sep 26, 2014. doi: 10.4252/wjsc.v6.i4.473

Full Size Figure Download Figure

Figure 2 This illustration shows combination therapies aiming to achieve maximal and synergistic anti-leukemia stem cells effect. HDACi: Histone deacetylase inhibitor; HMTi: Histone methyltransferase inhibitor; BETi: Bromodomain and Extra-Terminal inhibitor; Brd4: Bromodomain-containing protein 4; Ac: acetylation; Me: methylation; NK-cell: Natural killer-cell.

Citation: Zhou J, Chng WJ. Identification and targeting leukemia stem cells: The path to the cure for acute myeloid leukemia. World J Stem Cells 2014; 6(4): 473-484
URL: https://www.wjgnet.com/1948-0210/full/v6/i4/473.htm
DOI: https://dx.doi.org/10.4252/wjsc.v6.i4.473